|
1 |
03 03 2026 |
India Re-opens PLI Application Window for Critical Drug Production; Meropenem, Ritonavir in Focus |
Pharma News Live |
India |
|
2 |
03 03 2026 |
Pharma sector expect West Asia conflict to jack up input costs and cause export delivery delays |
Financial Express |
India |
|
3 |
03 03 2026 |
Health Ministry amends drug rules, Mandates Endotoxin testing and updates Licensing conditions. |
Medical Dialogues |
India |
|
4 |
03 03 2026 |
NPPA fixes retails prices of 20 new drug formulations under DPCO 2013 |
Medical Dialogues |
India |
|
5 |
03 03 2026 |
US-Iran escalation disrupts vital trade corridors, leaving Indian pharma on edge |
Money Control |
Iran |
|
6 |
03 03 2026 |
Big Pharma’s next entrant could come from China |
Pharma voice |
China |
|
7 |
02 03 2026 |
Telangana DCA issues stop production orders to several cos over Revised Schedule M non-compliance |
Pharmabiz |
India |
|
8 |
02 03 2026 |
MDC recommends exemption to Intas Pharma's patented antipsychotic formulation from DPCO for five years |
Pharmabiz |
India |
|
9 |
02 03 2026 |
DoP modifies incentive criteria for clinical investigations of medical devices under SDMI |
Pharmabiz |
India |
|
10 |
02 03 2026 |
CDSCO soon to engage QCI certified notified bodies to augment drug regulatory audit capacity: DCGI |
Pharmabiz |
India |
|
11 |
02 03 2026 |
KCDA asks Karnataka FDA to withdraw its recent circular on ‘Certificate of Analysis’ |
Pharmabiz |
India |
|
12 |
28 02 2026 |
Immediate NOC from June 1: CDSCO revises drug testing norms to Fast Track import , Manufacturing |
Medical Dialogues |
India |
|
13 |
28 02 2026 |
7 Pharma Firms Eye generic Semaglutide ,price may falls 50% post patent expiry: Report |
Medical Dialogues |
India |
|
14 |
28 02 2026 |
CDSCO cancels Kult App's cosmetic import registrations over False labeling |
Medical Dialogues |
India |
|
15 |
28 02 2026 |
Expired Drug repackaged? crime branch exposes Illegal Pharma racket near Patna. |
Medical Dialogues |
India |
|
16 |
28 02 2026 |
Andhra gets Rs.2,300 cr specialty Pharma boost from Blue jet |
Medical Dialogues |
India |
|
17 |
28 02 2026 |
Drug safety Alert : IPC flags blurred vision risk with Dacarbazine ,Sexual Dysfunction linked to Dolutegravir |
Medical Dialogues |
India |
|
18 |
28 02 2026 |
Government to target 1.15 crore HPV vaccinations yearly: Health ministry |
Health world (Economic Times) |
India |
|
19 |
28 02 2026 |
India moves closer to dengue vaccine as final trials underway |
Health world (Economic Times) |
India |
|
20 |
28 02 2026 |
CDSCO introduces SHRESTH index to improve performance of state drug regulatory authorities |
Pharmabiz |
India |
